MMP11

Matrix metallopeptidase 10
Identifiers
Symbol	?
HGNC	7165
OMIM	185260
Other data
EC number	3.4.24.22

Matrix metallopeptidase 10 (MMP10), also known as stromelysin-2, is an enzyme that in humans is encoded by the MMP10 gene. MMP10 is part of the matrix metalloproteinase (MMP) family, which is involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis.

Structure

MMP10 is a zinc-dependent endopeptidase. Like other MMPs, it is synthesized as an inactive proenzyme and is activated when cleaved by extracellular proteinases. The active enzyme consists of a catalytic domain that contains a zinc ion, which is essential for its proteolytic activity. The structure of MMP10 allows it to degrade various components of the extracellular matrix, including collagen, gelatin, and elastin.

Function

MMP10 plays a crucial role in the degradation of the extracellular matrix, which is important for tissue remodeling and repair. It is involved in processes such as wound healing, angiogenesis, and the inflammatory response. MMP10 is also implicated in pathological conditions, including cancer, where it can facilitate tumor invasion and metastasis by degrading the basement membrane and extracellular matrix components.

Regulation

The activity of MMP10 is tightly regulated at multiple levels, including transcription, activation of the proenzyme, and inhibition by tissue inhibitors of metalloproteinases (TIMPs). Dysregulation of MMP10 activity can lead to excessive matrix degradation and contribute to disease progression.

Clinical Significance

Elevated levels of MMP10 have been associated with various diseases, including rheumatoid arthritis, osteoarthritis, and cancer. MMP10 is considered a potential biomarker for disease progression and a target for therapeutic intervention. Inhibitors of MMP10 are being investigated for their potential to treat diseases characterized by excessive matrix degradation.

Research

Ongoing research is focused on understanding the precise role of MMP10 in different physiological and pathological contexts. Studies are also exploring the development of specific inhibitors that can modulate MMP10 activity without affecting other MMPs, to minimize side effects.

Also see

• Matrix metalloproteinase
• Tissue inhibitor of metalloproteinases
• Extracellular matrix
• Cancer metastasis